Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Janssen, a division of Ortho-McNeil-Janssen Pharmaceuticals, has launched an authorized generic version of Risperdal through Patriot Pharmaceuticals.
Subscribe to our email newsletter
Janssen has also announced that it will continue to make available branded Risperdal, which was first approved by the FDA in 1993.
Janssen’s Risperdal (risperidone) is indicated for the treatment of schizophrenia in adults and adolescents aged 13-17 years; and the treatment of irritability associated with autistic disorder in children and adolescents aged 5-16 years.